Regulatory Aspects of Drug Development

Harvard Extension School

BIOT E-220

Section 1

CRN 25749

Begin Registration
The course provides an overview of the prescription drug development process and regulatory considerations for this process, including small molecules, biologics, and gene therapy. It focuses on the phases of pharmaceutical development, aspects influencing the pharmaceutical industry, and the regulatory themes and healthcare concepts that shape the decisions having an impact on the entire process.

Registration Closes: January 23, 2025
Credits: 4

View Tuition Information

Term

Spring Term 2025

Part of Term

Full Term

Format

Live Attendance Web Conference

Credit Status

Graduate

Section Status

Waitlisted

Instructor Info

Jonathon Parker, PhD

Vice President, Head of Regulatory Neurology, Ultragenyx


Meeting Info

W 8:10pm - 10:10pm (1/27 - 5/17)

Participation Option: Online Synchronous

Deadlines

Last day to register: January 23, 2025

Notes

This course meets via web conference. Students must attend and participate at the scheduled meeting time.

Syllabus

Learn More

Tuition

View Tuition Information

All Sections of this Course

CRN Section # Participation Option(s) Instructor Section Status Meets Term Dates
25749 1 Online Synchronous Jonathon Parker Waitlisted W 8:10pm - 10:10pm
 Jan 27 to May 17

This Course May Contribute to: